Table 6 Association of each food intake pattern with hypertension, diabetes, hypercholesterolemia and elevated LDL cholesterol

Q1

Q2

Q3

Q4

p for trend

Q1

Q2

Q3

Q4

p for trend

Q1

Q2

Q3

Q4

p for trend

Men (N)

895

1061

1228

1509

1698

1127

909

959

947

1015

1185

1539

 Prevalence: n (%)

445 (49.8)

546 (51.6)

738 (60.3)

918 (60.8)

959 (56.5)

633 (56.3)

517 (56.9)

538 (56.2)

611 (64.5)

596 (58.7)

650 (54.9)

790 (51.3)

 OR^a (95% CI)

1 (ref)

0.75 (0.59–0.95)

0.83 (0.65–1.04)

0.67 (0.53–0.84)

0.003

1 (ref)

0.93 (0.76–1.14)

0.86 (0.69–1.06)

0.84 (0.68–1.05)

0.169

1 (ref)

1.13 (0.88–1.45)

1.20 (0.94–1.53)

1.41 (1.11–1.79)

0.008

 Prevalence: n (%)

110 (12.3)

148 (14.0)

214 (17.5)

271 (18.0)

245 (14.4)

176 (15.6)

149 (16.4)

173 (18.1)

179 (18.9)

199 (19.6)

184 (15.5)

181 (11.8)

 OR^a (95% CI)

1 (ref)

0.69 (0.48–1.00)

0.90 (0.64–1.27)

0.80 (0.57–1.11)

0.300

1 (ref)

0.92 (0.69–1.23)

0.87 (0.64–1.19)

0.92 (0.68–1.25)

0.839

1 (ref)

1.62 (1.17–2.25)

1.52 (1.09–2.12)

1.38 (0.98–1.95)

0.021

 Prevalence: n (%)

170 (19.0)

219 (20.7)

266 (21.7)

355 (23.5)

315 (18.6)

231 (20.5)

220 (24.2)

244 (25.5)

197 (20.8)

243 (23.9)

250 (21.1)

320 (20.8)

 OR^a (95% CI)

1 (ref)

1.01 (0.75–1.38)

0.94 (0.69–1.27)

0.94 (0.70–1.27)

0.853

1 (ref)

1.04 (0.79–1.36)

1.20 (0.90–1.60)

1.22 (0.92–1.62)

0.415

1 (ref)

1.45 (1.02–2.07)

1.34 (0.94–1.89)

1.64 (1.17–2.29)

0.036

 Prevalence: n (%)

161 (18.0)

200 (18.9)

234 (19.1)

314 (20.8)

270 (15.9)

213 (18.9)

206 (22.7)

220 (23.0)

190 (20.1)

217 (21.4)

223 (18.8)

279 (18.1)

 OR^a (95% CI)

1 (ref)

0.94 (0.67–1.30)

0.78 (0.56–1.10)

0.78 (0.56–1.09)

0.281

1 (ref)

1.19 (0.88–1.62)

1.40 (1.02–1.92)

1.18 (0.85–1.64)

0.228

1 (ref)

1.11 (0.75–1.64)

1.07 (0.73–1.57)

1.28 (0.89–1.85)

0.462

Women (N)

1589

1716

1748

1628

999

1715

1932

2033

2116

1923

1595

1045

 Prevalence: n (%)

439 (27.6)

697 (40.6)

778 (44.5)

835 (51.3)

461 (46.1)

727 (42.4)

782 (40.5)

779 (38.3)

1073 (50.7)

798 (41.5)

547 (34.3)

331 (31.7)

 OR^a (95% CI)

1 (ref)

1.05 (0.83–1.32)

1.13 (0.91–1.42)

1.03 (0.82–1.30)

0.507

1 (ref)

0.96 (0.75–1.23)

0.90 (0.70–1.14)

0.88 (0.69–1.11)

0.142

1 (ref)

1.05 (0.86–1.27)

1.00 (0.81–1.22)

1.03 (0.81–1.31)

0.840

 Prevalence: n (%)

100 (6.3)

141 (8.2)

141 (8.1)

171 (10.5)

97 (9.7)

146 (8.5)

146 (7.6)

164 (8.1)

207 (9.8)

177 (9.2)

102 (6.4)

67 (6.4)

 OR^a (95% CI)

1 (ref)

1.02 (0.70–1.48)

0.86 (0.59–1.26)

0.95 (0.66–1.38)

0.521

1 (ref)

0.78 (0.54–1.13)

0.71 (0.49–1.02)

0.75 (0.52–1.08)

0.061

1 (ref)

1.14 (0.85–1.55)

1.09 (0.77–1.53)

1.31 (0.88–1.96)

0.231

 Prevalence: n (%)

375 (23.6)

497 (29.0)

588 (33.7)

585 (35.9)

255 (25.5)

482 (28.1)

586 (30.3)

722 (35.5)

721 (34.1)

617 (32.1)

443 (27.8)

264 (25.3)

 OR^a (95% CI)

1 (ref)

0.92 (0.74–1.14)

1.02 (0.83–1.26)

0.84 (0.67–1.06)

0.237

1 (ref)

1.13 (0.87–1.46)

1.33 (1.04–1.71)

1.80 (1.41–2.29)

<0.001

1 (ref)

1.14 (0.94–1.38)

1.21 (0.99–1.48)

1.21 (0.96–1.53)

0.567

 Prevalence: n (%)

302 (19.0)

426 (24.8)

491 (28.1)

514 (31.6)

218 (21.8)

418 (24.4)

505 (26.1)

592 (29.1)

631 (29.8)

516 (26.8)

373 (23.4)

213 (20.4)

 OR^a (95% CI)

1 (ref)

1.06 (0.82–1.37)

1.12 (0.87–1.45)

1.05 (0.80–1.38)

0.755

1 (ref)

1.19 (0.86–1.62)

1.43 (1.06–1.93)

1.75 (1.30–2.35)

<0.001

1 (ref)

0.99 (0.78–1.24)

1.15 (0.91–1.46)

1.06 (0.80–1.40)

0.333